comprehensive -WSS

comprehensive

author：knowledge 2025-09-06 01:59:24 - browse：5

Steven Pearson — ICER President Steven D. Pearson Craig F. Walker/The Boston Globe

Meetings of the Institute for Clinical and Economic Review don’t usually get one’s heart pumping. But a meeting Thursday at the Massachusetts Institute of Technology may prove to be the exception to that rule.

Patients Rising Now, an advocacy group that says it promotes transparency in health care and that is a fierce opponent of ICER’s, is expected to face off with the self-professed “watchdog of drug pricing” as it reviews three drugs for Duchenne muscular dystrophy.

Dozens of Duchenne patients and their families — many of whom also express concern that ICER’s review could undermine insurers’ already tepid interest in the treatments — are also expected to be in attendance.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Evacuations in place as 3 wildfires burn in eastern Washington state

focus

WSS

What health policies could hitch a ride on a spending bill?

Today's health inequities arise from racist U.S. history, say experts

Type 2 diabetes prevention programs work at large scale: study

ProMED sees offers of support, but its future remains unclear

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

New details revealed about Purdue's marketing of OxyContin

hotspot

comprehensive

hotspot

At least 13 dead in Texas as scorching temps continue

Majority of Americans think Trump's Ga. election interference case is serious: POLL

What does generative AI mean for health care? We asked experts

A letter from the executive editor: STAT UnitedHealth investigation

As demand for Covid shots wanes, Moderna seeks its next success

Carbon Health diabetes program, a test of data

The high cost of giving birth even with insurance

Congress must give Medicare recipients genetic counseling access

Medicare details structure of new drug price negotiation program

Hilary expected to bring catastrophic, life

focus

Ohio still needs to do more to protect the right to abortion

Cancer diagnosis changes perspective doctor, former hospital CEO

Medicare’s new pay boost for primary care is angering specialists

ProMED sees offers of support, but its future remains unclear

Baltimore teen accused of firing into crowd during block party mass shooting

What health policies could hitch a ride on a spending bill?

Wikipedia

explore

focus

Wikipedia